longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge

Astria Therapeutics

ATXS

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
  • Weekly Recap | WuXi Biologics -0.93%, highs then a fade

    Weekly Review·Oct 10, 2026 at 08:14 AM
    WXXWY-2.97%
  • Weekly Recap | Upstream Bio -6.75%, consensus target above spot

    Weekly Review·Oct 10, 2026 at 08:03 AM
    UPB-10.00%
  • Weekly Recap | Tango Therapeutics +2.45%, most brokers rate it buy

    Weekly Review·Oct 10, 2026 at 07:54 AM
    TNGX+2.52%
  • Weekly Recap | Prime Medicine +33.89%, most brokers rate it buy

    Weekly Review·Oct 10, 2026 at 07:24 AM
    PRME-8.40%
  • Weekly Recap | Oncolytics Biotech -11.73%, hitting a one-month low

    Weekly Review·Oct 10, 2026 at 07:22 AM
    ONCY-14.81%
  • Weekly Recap | Beigene -1.01%, most brokers rate it buy

    Weekly Review·Oct 10, 2026 at 07:17 AM
    ONC-0.89%
  • Weekly Recap | Legend Biotech +0.27%, most brokers rate it buy

    Weekly Review·Oct 10, 2026 at 06:58 AM
    LEGN-3.92%
  • Weekly Recap | Insmed -9.47%, brokers stay strong buy

    Weekly Review·Oct 10, 2026 at 06:54 AM
    INSM-1.85%
  • Weekly Recap | Inovio Pharma -0.86%, most brokers rate it buy

    Weekly Review·Oct 10, 2026 at 06:52 AM
    INO-3.48%
  • Weekly Recap | ImmunityBio +2.19%, Friday's 8.17% gain erases weekly slump

    Weekly Review·Oct 10, 2026 at 06:50 AM
    IBRX-2.90%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy